在心力衰竭中,他类药物的预后影响与保存的喷射分数
Samanta Ortega-Hernández1, Sonia González-Sosa1,2, Alicia Conde-Martel1,2
1Internal Medicine Department, Hospital Universitario de Gran Canaria Dr. Negrín, 35010 Las Palmas de Gran Canaria, Las Palmas, Spain.
Journal of clinical medicine
|October 16, 2024
概括
类他类药物可能会降低心力衰竭的死亡率,并保持喷射分数 (HFpEF). 这种益处主要在没有缺血性心脏病 (IHD) 的患者中观察到.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭缺乏有效的降低死亡率的治疗方法.
- 以前的研究表明,他类药物可能会降低HFpEF患者的死亡率.
- 对于他类药物治疗对HFpEF死亡率的影响,特别是对于缺血性心脏病 (IHD) 的影响,需要进一步研究.
研究的目的:
- 为了确定类他类药物治疗是否与HFpEF患者的死亡率降低有关.
- 调查这种关联是否根据IHD的存在或不存在而有所不同.
主要方法:
- 分析来自国家心力衰竭登记处的数据,这是一项前性的全国性研究.
- 将HFpEF患者分为治疗他类药物和非治疗他类药物组.
- 多变量考克斯回归分析以确定死亡率的独立预测因素.
主要成果:
- 总共有2788名HFpEF患者被纳入; 40.2%接受了他类药物.
- 接受他类药物治疗的患者年轻,功能状况更好,血管疾病较多.
- 多变量分析显示,他类药物使用者的1年死亡率显著降低 (OR:0.74;95%CI:0.61-0.89;p=0.002),主要是在没有IHD (p<0.001) 的患者中.
结论:
- 静止剂治疗与诊断为HFpEF的患者的整体死亡率降低有关.
- 在HFpEF中,他类药物的死亡益处似乎集中在没有IHD病史的患者中.
- 进一步的研究可能会阐明基于IHD状态的HFpEF的机制和完善治疗策略.
更多相关视频
07:09A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
1.8K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
579
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
579
01:22Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
01:30Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2